Expert Insights
Content Hubs
Themes
Active ETFs
Free Cash Flow
Alternatives
Future ETFs
Artificial Intelligence
Innovative ETFs
China Insights
Institutional Income Strategies
CoinShares
Leveraged & Inverse
Core Strategies
Market Insights
Crypto
Market Outlooks
Disruptive Technology
Modern Alpha
Energy Infrastructure
Nuclear Energy
ETF Building Blocks
Portfolio Strategies
ETF Investing
Sector Investing
ETF Strategist
Tax Efficient Income
Financial Literacy
Thematic Investing
Fixed Income
Asset Class
Equity
Emerging Market Equities
Int'l Developed
U.S. Equity
Fixed Income
High Yield Corporates
Int'l Fixed Income
Investment Grade Corporates
US Treasuries & TIPS
Alternatives
Gold/Silver/Critical Materials
Cryptocurrency
Currency
Volatility
ETF Ecosystem
ETFs in Canada
Market Outlook
Exchange
CoinShares
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA - iShares MSCI EAFE ETF
IEMG – iShares Core MSCI Emerging Markets ETF
EEM – iShares MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX - VanEck Vectors Gold Miners ETF
XLF - Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV - Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
Education & Media
Newsletter
New ETFs
Education Central
Videos
ETF of the Week Podcast
ETF Prime Podcast
Gaining Perspective
ETF 360 Video Series
Sectors
Sector Investing Content Hub
Sector Power Rankings
XLK
XLE
XLI
XLC
XLU
XLF
XLY
XLV
XLP
XLB
XLRE
Events
Asset Allocation Summit
Midyear Market Outlook
2027 Market Outlook
Q2 Market Outlook
Winter Symposium
Company
About VettaFi
Get VettaFi’ed
Biotechnology
Featured
Sell-Off in Biotech ETFs Could Be a Temporary Setback
By
Tom Lydon
October 10, 2013
Featured
Wicked Wednesday for Some Beloved ETFs
By
Tom Lydon
October 9, 2013
Featured
Unearth This Hidden ETF if Biotech’s Decline is Real
By
Tom Lydon
October 9, 2013
Featured
10 ETF Investments That Got the Most Bang for Your Buck
By
Tom Lydon
October 8, 2013
Featured
ETF Categories That Just Keep On Winning
By
Gary Gordon
October 2, 2013
Featured
Biotech The Equal-Weight Way
By
Tom Lydon
September 25, 2013
Featured
Smaller Biotech ETF Hangs With The Big Boys
By
Tom Lydon
September 6, 2013
Featured
A Biotech ETF for Up-and-Coming Drug Developers
By
Tom Lydon
September 5, 2013
Featured
Three ETFs to Play Up-and-Coming Health Care Companies
By
Tom Lydon
September 3, 2013
Featured
Hunting for Bargains in Sector ETFs
By
Tom Lydon
August 23, 2013
Featured
Three ETFs to Play the Outperforming Biotech Sector
By
Tom Lydon
August 19, 2013
Featured
Biotech, Tech ETFs Could Lead Into Year-End
By
Tom Lydon
August 7, 2013
Featured
Biotech ETFs Shine in July
By
Tom Lydon
August 1, 2013
Featured
ETF Performance Report: July
By
Tom Lydon
July 31, 2013
Featured
Onyx Rally Powers Biotech ETFs
By
John Spence
July 1, 2013
Featured
Biotech ETF Rallies Over 30% as Cash Tumbles In
By
John Spence
May 22, 2013
Featured
Positive Prognosis for Biotech ETFs
By
Tom Lydon
May 10, 2013
Featured
Investors Clamor for Generic Drug ETF
By
Tom Lydon
May 6, 2013
Previous
1
…
15
16
17
18
19
…
26
Next
X